Slu pp 332 | 5MG

Description

 SLU-PP-332 500 mcg per tablet

Researchers developed SLU-PP-332, a synthetic small-molecule compound, for studying metabolic regulation and mitochondrial function. It is primarily studied for its ability to activate estrogen-related receptors (ERRs), a family of nuclear receptors involved in energy metabolism, oxidative phosphorylation, and mitochondrial biogenesis.

Researchers have investigated SLU metabolism in preclinical research models as an exercise-mimetic compound, meaning it can induce molecular pathways similar to those activated by endurance exercise. These pathways include enhanced fatty acid oxidation, increased mitochondrial efficiency, and upregulation of genes associated with aerobic capacity and energy expenditure, particularly in skeletal muscle tissue.